The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review

Abstract

Mahmalji (2020) The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review,

Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review

“…After removing duplicates, 461 records were screened for eligibility based on title and abstract, of which 36 records were selected for full-text review. Twenty-five articles were included in the systematic review, of which six were from an RCT, [11][12][13][14][15][16] six were from five prospective studies [17][18][19][20][21][22] in which two articles were of the same study 18,19 and one article was of the crossover arm from the RCT, 17 eleven were from retrospective studies, [23][24][25][26][27][28][29][30] and two were from case series 31,32 (Figure 1).…”

“…McVary et al 27 Baboudjian et al 34 Bassily et al 35 Besides the pilot study by Dixon et al 18,19 all the studies were conducted in the United States before 2020. [11][12][13][14][15][16][17]23,24 Recently, however, more studies have been conducted in different countries including France, 26,30,34 United Kingdom, 21,31 Italy, 22 and Ireland. 32 Sample size and patient follow-up in each study ranged from 10 to 255 patients (median 65 patients) and 1 to 60 months (median 12 months), respectively ( 2).…”

“…Mean procedure time ranged from 4.4 to 13.0 minutes (median 7.0 minutes). Out of the 19 studies, 11-35 14 [11][12][13][14][15][16][18][19][20][21][22][24][25][26][27][28][29][30][31][32][33][34][35] reported postoperative urinary catheter rates which ranged from 65% to 100%, with 13 studies 21,22,[25][26][27][28][29][30][31][32][33][34][35] having a rate of 100%. The mean number of days patients were catheterized postoperatively ranged from 3.0 to 32.2 days, with the upper limit reserved for those who had urinary retention at baseline (Table 3).…”

“…Eleven studies [11][12][13][14][15][16][17][18][19]23,24,26,27,[31][32][33]35 treated patients with an obstructing median lobe. Patients who had treatments to the median lobe experienced similar or greater improvements in LUTS when compared to patients who did not have treatments to the median lobe.…”

“…In addition to treating patients with obstructing median lobes, Rezum has also been shown to effectively treat patients with urinary retention and large prostate volumes (≥80 g). Nine studies [21][22][23][26][27][28]31,34,35 treated patients with urinary retention and reported an overall catheter-free rate in 158/190 patients (83%, range 68%-100%), of which five studies 26,27,31,34,35 reported achieving it at a median of 14 days (range 13-2 days) following treatment.…”